298 related articles for article (PubMed ID: 23861927)
1. Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.
Mattace Raso G; Simeoli R; Russo R; Iacono A; Santoro A; Paciello O; Ferrante MC; Canani RB; Calignano A; Meli R
PLoS One; 2013; 8(7):e68626. PubMed ID: 23861927
[TBL] [Abstract][Full Text] [Related]
2. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
[TBL] [Abstract][Full Text] [Related]
3. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
[TBL] [Abstract][Full Text] [Related]
4. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet.
Raso GM; Simeoli R; Iacono A; Santoro A; Amero P; Paciello O; Russo R; D'Agostino G; Di Costanzo M; Canani RB; Calignano A; Meli R
J Nutr Biochem; 2014 Jan; 25(1):81-90. PubMed ID: 24314869
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
[TBL] [Abstract][Full Text] [Related]
7. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver.
Lu CH; Hung YJ; Hsieh PS
Eur J Pharmacol; 2016 Oct; 789():60-67. PubMed ID: 27397427
[TBL] [Abstract][Full Text] [Related]
8. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C
Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats.
Xia HM; Wang J; Xie XJ; Xu LJ; Tang SQ
Int J Mol Med; 2019 Oct; 44(4):1523-1530. PubMed ID: 31364723
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
11. Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation.
Sun B; Jia Y; Hong J; Sun Q; Gao S; Hu Y; Zhao N; Zhao R
J Agric Food Chem; 2018 Jul; 66(29):7633-7642. PubMed ID: 29961332
[TBL] [Abstract][Full Text] [Related]
12. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
13. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
15. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats.
Adeyanju OA; Badejogbin OC; Areola DE; Olaniyi KS; Dibia C; Soetan OA; Oniyide AA; Michael OS; Olatunji LA; Soladoye AO
Biomed Pharmacother; 2021 Jan; 133():110994. PubMed ID: 33197764
[TBL] [Abstract][Full Text] [Related]
17. Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice.
Mollica MP; Mattace Raso G; Cavaliere G; Trinchese G; De Filippo C; Aceto S; Prisco M; Pirozzi C; Di Guida F; Lama A; Crispino M; Tronino D; Di Vaio P; Berni Canani R; Calignano A; Meli R
Diabetes; 2017 May; 66(5):1405-1418. PubMed ID: 28223285
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis.
Zhang W; Xu YZ; Liu B; Wu R; Yang YY; Xiao XQ; Zhang X
ScientificWorldJournal; 2014; 2014():603409. PubMed ID: 24558317
[TBL] [Abstract][Full Text] [Related]
20. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
